Servicios
Descargas
Buscar
Idiomas
P. Completa
The effect of the vaccine on the severity of infection on children with mumps
Venus Hassan Abdul Amir
Venus Hassan Abdul Amir
The effect of the vaccine on the severity of infection on children with mumps
El efecto de la vacuna sobre la gravedad de la infección en niños con paperas
Revista Latinoamericana de Hipertensión, vol. 16, núm. 1, pp. 37-39, 2021
Sociedad Latinoamericana de Hipertensión
resúmenes
secciones
referencias
imágenes

Abstract: A hundred patients were diagnosed with mumps virus in children with fever, fatigue, and swelling in one or both of salivary glands (parotitis). ELISA was used to test mumps specific immunoglobulin M (IgM) antibodies. Of 100 kids tested, (59%) had earlier been vaccinated against mumps, while (41%) had not been vaccinated. (73%) had mumps IgM antibodies. Of these, (56.1%) had been vaccinated for mumps, while (43.8%) had not. The results indicated significant difference between severity of infection and vaccination status.

Keywords:ChildrenChildren,ELISAELISA,InfectionInfection,Mumps VirusMumps Virus,VaccineVaccine.

Resumen: Cien pacientes fueron diagnosticados con el virus de las paperas en niños con fiebre, fatiga e hinchazón en una o ambas glándulas salivales (parotiditis). Se utilizó ELISA para analizar los anticuerpos inmunoglobulina M (IgM) específicos de las paperas. De 100 niños evaluados, (59%) habían sido vacunados anteriormente contra las paperas, mientras que (41%) no habían sido vacunados. (73%) tenía anticuerpos IgM contra las paperas. De estos, (56,1%) habían sido vacunados contra las paperas, mientras que (43,8%) no. Los resultados indicaron una diferencia significativa entre la gravedad de la infección y el estado de vacunación

Palabras clave: Niños, ELISA, Infección, Vacuna, Virus de las Paperas.

Carátula del artículo

Artículos

The effect of the vaccine on the severity of infection on children with mumps

El efecto de la vacuna sobre la gravedad de la infección en niños con paperas

Venus Hassan Abdul Amir
University/Iraq, Irak
Revista Latinoamericana de Hipertensión, vol. 16, núm. 1, pp. 37-39, 2021
Sociedad Latinoamericana de Hipertensión

Recepción: 28 Diciembre 2020

Aprobación: 15 Enero 2021

Publicación: 10 Febrero 2021

Introduction

Mumps is recognized as a remarkable vaccine-avoidable infantile viral illness1. The experimental images of mumps virus (MuV) contagion is branded by discomfort and bulge of the parotid glands, nonetheless can include numerous additional matters besides structures2. It container reason severe difficulties counting inflammation of the brain, meninges, one or both of the testicles, heart muscle, pancreas, and kidneys2,3. While mumps is a kindly sickness, frequently through whole retrieval in a insufficient weeks next existence diseased, extended-word products, such as appropriations, cranial chord silencing, fluid accumulates in the brain, plus impaired hearing, can happen3,4. Owing to its benevolent scientific representation, mumps takes been rather deserted likened thru extra communicable syndromes (e.g., measles). But, in 2016 and 2017, the amount of suitcases of mumps amplified nearly two-periods associated to persons stated in the preceding five ages in the United States (US)5. Moreover, in new years, some vast eruptions of the mumps contamination have been described in advanced nations6. In what way to stop and switch the widespread of mumps has flashed a novel tricky of community fitness. Preceding bang displayed that 70% of infected persons per identified immunization past had conventional two dosages of measles, mumps, and rubella (MMR) inoculation previous to complaint5. Related to mumps, bags of measles and rubella seldom arise in individual with two prescriptions of MMR preparation, signifying certain features of mumps vaccine effects its usefulness3.

Materials and Methods

Study groups

The patients

100 samples were collected from patients with fever, fatigue, and swelling in one or both of salivary glands (parotitis) who were admitted to Babel Teaching Hospital for Maternity and Children in Al-Hilla city during the period from 2019 to 2020. The patients were ≤ 5 years old.

Sample Collection

Three ml of whole blood obtained by venipuncture from all subjects studied after cleaning the skin with 70% alcohol. These samples were collected in a gel tube with 2 mL which was left for thrombosis and the serum was centrifuged at 3,000 rpm (5) for 10 minutes, then the serum tasters were prudently moved to Eppendorf tubes then kept at -20°C till use.

The study parameters

A. Immunity test:

Serum was tested for mumps specific IgM antibodies with ELISA (Elabscince-China) technique in patients.

B. Statistical analysis

It was done by SPSS form 20 in this training. A p ≤ 0.05 was significant.

Results and discussion

One hundred samples of children with mumps, including vaccinated and unvaccinated, were subjected to this study by using mumps-specific IgM detection ELISA. The results indicated 60% male, 59% vaccinated, and 66% was mild infection (table 1).

Table 1
Distribution of clinical evidence among children with mumps

Mumps remained a thoughtful malady that source noteworthy indisposition and death universal beforehand the package of mumps inoculation preliminary. Throughout the pre-vaccine epoch, mumps was mingling chronic disease with an episodic point of two to five centuries and a highest prevalence of taint between offspring matured five to seven eons old in some areas internationally7. Mump impurities normally befell in packed populace middles, e.g., penitentiaries, playschools, lodging universities, armed quarters, and added alike full locations8. A number of hazard issues must have been informed in mumps impurity as well as stage, contact, cooperated protection, phase of time, portable, and vaccination rank. Even though here is not at all indication of a change on manifestation of MuV toxicities amid the genders, men proper have greater threat to contemporary hitches8,9. Former serostudy lessons were showed in more than a few republics erstwhile to the outline of vaccines10. They exhibited that 50% of kids young four to six years ancient too 90% of children aged 14–15 years old stood sero optimistic, with a sheer upsurge in mumps antibody planes at two to three years of oldness. These marks direct that virtually altogether those deprived of getting mumps vaccination resolve ultimately convert sick11.

Of the 100 children tested for mumps IgM, 73 (73%) tested positive for mumps IgM antibodies, including 41 (56.1%) vaccinated, and 32 (43.8%) un vaccinated (table 2). The outcomes revealed substantial variance amongst strictness of contagion and vaccination rank.

Table 2.
Distribution between severity of infection and vaccination status among children infected with mumps

The proportion of mumps infection was critically compact subsequently the starter of mumps jab. The epidemiologic arrangement of mumps altering is founded on the many injection database, such as the sum of measures of vaccination, era at shot, and vaccine attention. The analysis percentage of mumps vaccination growths, the typical oldness on dirt surges pending the equal of seropositive inhabitants wanted to halt feast of mumps has been located reached10,12. Doubt vaccine reporting percentage is not enough, it canister main to an intensification in the drain of spartan consequence as the ailment swings to grownup age collections in which mumps worries are further dominant13. Granting mumps was originally fruitfully exact by vaccination in established kingdoms, random mumps rashes instigated to transpire totally14 . Quite a lot of explanations were upraised to clarify the unforeseen incident: weakening invulnerability15; the worth of mumps vaccine, which has diverse rendering toward the prescribed amount of shots and poles apart virus stress recycled aimed at manufacture of the mumps vaccine16; also by what means abundant the side by side of antibody keep at in frame by way of stretch once vaccination otherwise unusual septicity surrounded by residents7.

Material suplementario
References
1. Hviid A, Rubin S, Muhlemann K. Mumps. Lancet.2008;371:932–944.
2. Betáková T, Svetlíková D, Gocník M. Overview of measles and mumps vaccine: Origin, present, and future of vaccine production. Acta Virol.2013;57:91–96.
3. Rubin S, Kennedy R, Poland G. Emerging mumps infection. Pediatr. Infect. Dis. J.2016;35:799–801.
4. Wellington K, Goa KL. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): A review of its use in the prevention of measles, mumps and rubella. Drugs.2003;63:2107–2126.
5. Marlow MA, Marin M, Moore K, Patel M. CDC guidance for use of a third dose of MMR vaccine during outbreaks. J. Public Health Manag. Pract.2020;26:109–115.
6. Van Loon FP, Holmes SJ, Sirotkin BI, Williams WW, Cochi SL, Hadler SC, Lindegren ML. Mumps surveillance—United States, 1988–1993. MMWR CDC Surveill. Summ.1995;44:1–14.
7. Marlow R, Kuriyakose S, Mesaros N, Han HH, Tomlinson R, Faust SN, Snape M, Pollard AJ, Finn A. A Phase III, open-label, randomized multicenter study to evaluate the immunogeneicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4 year-old healthy children in the UK. Vaccine.2018;36;2300–2306.
8. Osborne K, Gay N, Hesketh L, Morgan-Capner P, Miller E. Ten years of serological surveillance in England and Wales: Methods, results, implications and action. Int. J. Epidemiol.2000;29:362–368.
9. Edmunds WJ, Gay NJ, Kretzschmar M, Pebody RG, Wachmann H. ESEN Project. European Sero-epidemiology Network. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: Implications for modelling studies. Epidemiol. Infect. 2000;125:635–650.
10. Béraud G, Abrams S, Beutels P, Dervaux B, Hens N. Resurgence risk for measles, mumps and rubella in France in 2018 and 2020. Eurosurveillance.2018;23.
11. 11. Galazka AM, Robertson SE, Kraigher, A. Mumps and mumps vaccine: A global review. Bull. World Health Organ. 1999;77, 3–14.
12. Metcalf CJE, Graham AL, Grenfell BT. Understanding Herd Immunity. Trends Immunol.2015;36:753–755.
13. LeBaron CW, Forghani B, Matter L, Reef SE, Beck C, Bi D, Cossen C, Sullivan BJ. Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine. J. Infect. Dis.2009;200:888–899.
14. Fields VS, Safi H, Waters C, Dillaha J, Capelle L, Riklon S, Wheeler JG, Haselow DT. Mumps in a highly vaccinated Marshallese community in Arkansas, USA: An outbreak report. Lancet Infect. Dis.2019;19:185–192.
15. Schwarz NG, Bernard H, Melnic A, Bucov V, Caterinciuc N, an der Heiden M, Andrews N, Pebody R, Aidyralieva C, Hahné S. Mumps outbreak in the Republic of Moldova, 2007–2008. Pediatr. Infect. Dis. J. 2010;29:703–706.
16. Castilla J, García Cenoz M, Arriazu M, Fernández-Alonso M, Martínez-Artola V, Etxeberria J, Irisarri F, Barricarte A. Effectiveness of Jeryl Lynn-containing vaccine in Spanish children. Vaccine.2009;27:2089–2093.
Notas
Table 1
Distribution of clinical evidence among children with mumps

Table 2.
Distribution between severity of infection and vaccination status among children infected with mumps

Buscar:
Contexto
Descargar
Todas
Imágenes
Visor de artículos científicos generados a partir de XML-JATS4R por Redalyc